Sort
261,768 grants matching “gene therapy”
Definitive Preclinical Studies of Hydrolase Gene Transfer to Treat Cocaine Abuse
$1,430,948William S Brimijoin · Mayo Clinic Rochester · UG3 · FY2016 · DA
Rational approaches to melanoma therapy
$1,430,873Meenhard Herlyn · Wistar Institute · U54 · FY2019 · CA
Biorepository for Investigation of Neonatal Diseases of Lung-Normal (BRINDL-NL)
$1,430,776Gloria S Pryhuber · University Of Rochester · U01 · FY2016 · HL
1/5: A Genome-wide Methylation Scan for Epigenetic Contributions to Schizophrenia
$1,430,539Andrew P Feinberg · Johns Hopkins University · U01 · FY2010 · MH
Targetable epigenetic and transcriptional mechanisms in melanoma that shape the microenvironment
$1,430,472David E Fisher · Massachusetts General Hospital · P01 · FY2022 · CA
Remodeling and recovery in the neurovascular unit
$1,430,225Eng H. Lo · Massachusetts General Hospital · P01 · FY2014 · NS
A Pilot Clinical Study in Acute STEMI
$1,430,128Weizhong Cai · Angion Biomedica Corporation · R44 · FY2010 · HL
GENETIC ALTERATIONS ON LIPOPROTEINS AND ATHEROSCLEROSIS
$1,430,113J. David Gladstone Institutes · P01 · FY2000 · HL
SCAN-MP (Screening for Cardiac Amyloidosiswith Nuclear imaging in Minority Populations)
$1,429,986Mathew S Maurer · Columbia University Health Sciences · R01 · FY2021 · HL
Center for Research Translation in Scleroderma
$1,429,620Frank C Arnett · University Of Texas Hlth Sci Ctr Houston · P50 · FY2008 · AR
Biorepository for Investigation of Neonatal Diseases of Lung-Normal (BRINDL-NL)
$1,429,584Gloria S Pryhuber · University Of Rochester · U01 · FY2017 · HL
GENE EXPRESSION OF COLON CANCERS THAT METASTASIZE
$1,429,417Case Western Reserve University · U01 · FY2001 · CA
The Inherited Neuropathy Consortium (INC) RDCRC- Overall
$1,429,411Michael E Shy · University Of Iowa · U54 · FY2022 · NS
Androgen Receptor Action in Castration Resistant Prostate Cancer
$1,429,408Steven P. Balk · Beth Israel Deaconess Medical Center · P01 · FY2022 · CA
Interdisciplinary Investigation of Biological Signatures of Autism Subtypes
$1,429,402David G Amaral · University Of California At Davis · R01 · FY2009 · MH
SP-A as an immune modulator
$1,429,197Monica Kraft · Duke University · P01 · FY2012 · AI
Therapeutic approaches for ABCA4-associated disorders
$1,429,108Rando L Allikmets · Columbia University Health Sciences · R24 · FY2015 · EY
In Vivo Cellular and Molecular Imaging Center@Stanford
$1,429,105Sanjiv S Gambhir · Stanford University · P50 · FY2012 · CA
Washington University Molecular Imaging Center
$1,428,925David R Piwnica-Worms · Washington University · P50 · FY2012 · CA
WU-MDACC Inter-Institutional Molecular Imaging Center
$1,428,925Samuel Achilefu · Washington University · P50 · FY2015 · CA
Metabolic regulation of T cell effector function and anti-tumor immunotherapy
$1,428,684Naomi Taylor · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Reprogramming hematopoietic stem cell (HSC) differentiation via metabolic condit
$1,428,684Naomi Taylor · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Implementing a coupled system of integrative ML modeling and data validation for elucidating microglial therapeutic targets in neurodegenerative disease
$1,428,644Karen Sachs · Modulo Bio, Inc. · R44 · FY2024 · MH
International Center for Excellence in Research (ICER) in Uganda: Impact of ARVs
$1,428,469Thomas Quinn · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
DNA repair
$1,428,454Andre A. Nussenzweig · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA